Donor Dendritic Cells And Donor Lymphocytes in Patients With Relapsed Hematologic Malignancies After Allogeneic Transplant

This study has been completed.
Brigham and Women's Hospital
Beth Israel Deaconess Medical Center
National Cancer Institute (NCI)
Information provided by (Responsible Party):
Edwin P. Alyea, MD, Dana-Farber Cancer Institute Identifier:
First received: May 18, 2007
Last updated: March 28, 2012
Last verified: March 2012
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: July 2009
  Primary Completion Date: August 2007 (Final data collection date for primary outcome measure)